DOCSLIB.ORG

Liraglutide Modulates Adipokine Expression During Adipogenesis, Ameliorating Obesity, and Polycystic Ovary Syndrome in Mice

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Liraglutide Modulates Adipokine Expression During Adipogenesis, Ameliorating Obesity, and Polycystic Ovary Syndrome in Mice Endocrine (2019) 64:349–366 https://doi.org/10.1007/s12020-019-01891-3 ORIGINAL ARTICLE Liraglutide modulates adipokine expression during adipogenesis, ameliorating obesity, and polycystic ovary syndrome in mice 1 2 3 1 2 Anusha Singh ● Joseph R. D. Fernandes ● Gagan Chhabra ● Amitabh Krishna ● Arnab Banerjee Received: 9 October 2018 / Accepted: 5 March 2019 / Published online: 23 March 2019 © Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract Purpose The incidence of obesity is increasing among all age groups throughout the world and it is highly associated with numerous other metabolic disorders, such as insulin resistance, polycystic ovarian syndrome (PCOS) etc. Methods and Results Using in vitro and in vivo approach, this study investigated the adipokine profile after liraglutide on differentiated murine 3T3-L1 pre-adipocytes. Effect of liraglutide on DHEA-induced PCOS mice were investigated. This study showed Liraglutide treatment resulted in up-regulation of adiponectin and IL-6 along with down-regulation of ICAM 1 in differentiated 3T3-L1 cells. Liraglutide in absence of other differentiating factors, significantly increased glucose, lipid uptake and PPARγ, C/EBPα expression in the adipocytes suggesting its ability to solely promote pre-adipocyte differ- 1234567890();,: 1234567890();,: entiation into mature adipocyte. Liraglutide treatment showed increased adiponectin expression and decreased number of cystic follicles, body weight, circulating glucose, triglyceride and testosterone levels in comparison to the PCOS induced mice. Conclusion This study suggests that adiponectin may act as a link between metabolic disorders and PCOS and that liraglutide might be a promising therapeutic agent for the treatment of PCOS in addition to obesity and insulin resistance. Highlights ● The study shows the impact of GLP-1 analogue, liraglutide’s impact on adipokine secretion in 3T3L1 adipocytes. ● For the first time, showing that liraglutide in the absence of other differentiating factors (IBMX, insulin, and dexamethasone), significantly increased glucose, lipid uptake and PPARγ, C/EBPα expression in the adipocytes suggesting its ability to solely promote pre-adipocyte differentiation into mature adipocyte. ● Also, for the first time it shows that liraglutide through the up-regulation of adiponectin manages PCOS in mice. Keywords Liraglutide ● Adipocyte ● Adiponectin ● PCOS These authors contributed equally: Anusha Singh, Joseph R. D. Fernandes * Arnab Banerjee 2 Department of Biological Sciences, BITS Pilani KK Birla Goa [email protected] Campus, Goa 403726, India 3 Department of Dermatology, University of Wisconsin-Madison, 1 Department of Zoology, Banaras Hindu University, Madison, WI, USA Varanasi 221005, India 350 Endocrine (2019) 64:349–366 Introduction Both liraglutide and GLP-1 share, some of the glucor- egulatory functions including enhancement of glucose- Obesity constitutes a serious health concern worldwide. It is dependent insulin secretion, inhibition of postprandial glu- alarming to observe obesity among all age groups in most cagon secretion, inhibition of gastric emptying, and reduc- countries including India [1]. It is a major characteristic of tion of food intake [16]. In animal studies, liraglutide metabolic syndrome and is a risk factor for type II diabetes maintenance of β-cell mass in diabetes, by inhibiting both and cardiovascular diseases [2]. Earlier anti-obesity drugs or cytokine and free fatty acid (FFA)-induced apoptosis [17]. anorexins have poor safety records. A better knowledge of Recently, a study showed that liraglutide prevented the physiology of adipogenesis and fat cell development in hypoadiponectinemia-induced increase in plasma insulin obesity is important to identify new biomarkers and ther- [18]. Liraglutide injection into high fat diet fed mice apeutic targets for the development of novel anti-obesity induced in vivo adipocyte differentiation by regulating cell drugs with improved safety profile. proliferation and apoptosis of pre-adipocytes [19]. In type II Factors responsible for obesity include those responsible diabetes patients, 14 weeks of liraglutide treatment sig- for the expansion of white adipose tissue via the mechanism nificantly reduced hemoglobin A1c (HbA1c), body mass of hypertrophy of pre-existing adipocytes and hyperplasia index, and total body fat mass, lowered insulin resistance resulting from the adipogenesis of pre-adipocytes [3]. and increased visfatin and resistin levels [20]. A recent However, changes in adipocyte turnover rate, differentia- study showed that liraglutide facilitates weight loss, tion, and apoptosis could all contribute to changes in fat improving bleeding pattern, increased SHBG levels, and mass underlying obesity. Studies have suggested that pre- decreased testosterone levels thereby improving the sex adipocyte differentiation may be impaired in obese humans hormone levels and gonadotropin levels further ameliorat- [4, 5]. One possible avenue to reduce fat mass is to ther- ing other metabolic dysfunction in overweight women with apeutically regulate pre-adipocyte differentiation, but a PCOS. This study also assessed the ovarian morphology better understanding of the pathways controlling adipo- with three-dimensional ultrasound, however, no effect was genesis is needed. Another important aspect of adipogenesis observed in both the liraglutide and the placebo groups [21]. is the adipokines secretion by the adipose tissue, which is The study showed when women with PCOS were treated the central factor how fat mass directly influence insulin with liraglutide, the levels of fasting glucose and leptin were sensitivity and vascular injury [6]. The success of any new reduced, however, measures of insulin resistance, adipo- drug to control obesity depends on how therapeutically it nectin, and glucagon strangely did not change. This study might regulate the profile of adipokines secreted from the further showed liraglutide treatment of 26 weeks in PCOS fat mass. women resulted in significant reductions of liver fat content, Glucagon-like peptide 1 (GLP-1), is a proglucagon- VAT, and the prevalence NAFLD [22]. Another study derived peptide secreted from endocrine cells in the gut, showed that treatment with liraglutide in combination with GLP-1 is used as a therapeutic option for the pharma- metformin resulted in a significant weight loss in over- cotherapy of type II diabetes and obesity. It is responsible weight and obese women with PCOS [23]. 3T3-L1 cells for the stimulation of glucose-dependent insulin secretion treated with different doses of liraglutide, showed a sig- from pancreatic β cells, inhibition of glucagon secretion, nificant decrease in the mRNA expression of some adipo- and inhibition of food intake [7–10]. Obese individuals are kines, such as leptin, TNF-α, and IL-6, whereas, the mRNA reported to have reduced GLP-1 levels and improved GLP- expression of adiponectin and CTRP3 were increased sig- 1 levels after weight loss [11]. One of the major short- nificantly [24]. Interestingly, liraglutide treatment to type II comings in the implementation of GLP-1 is its rapid inac- diabetes patients has also been shown to significantly tivation in the body by the enzyme dipeptidyl peptidase IV decrease serum adiponectin level [25] and among Chinese (DPP-IV) and rapid renal elimination [7]. Studies have type 2 diabetes (T2DM) patients, liraglutide led to increased shown the effects of GLP-1 on cardiomyocytes involving in adiponectin and decreased resistin levels [26]. However, the the regulation of the PI3K/Akt signaling pathway [12–14]. direct effect of liraglutide on the adipokine profile of the For the gut–brain axis, GLP-1 and GLP-2 are important for differentiated pre-adipocyte is not known, knowledge of food intake, maintaining glucose homeostasis thereby con- which will not only help us to better understand the phy- trolling insulin sensitivity through the PI3K/Akt signaling siology of liraglutide action on adipocytes but also might pathway [15]. To overcome this shortcoming, a long-acting open new research pertaining liraglutide pharmacotherapy. analogue of GLP-1, liraglutide, with a 97% sequence The murine 3T3-L1 cells are one of the best in vitro homology to human GLP-1 has been increasingly used as a models to study the mechanisms involved in pre-adipocyte therapeutic agent in improving insulin resistance, glucose proliferation, differentiation, adipokine secretion, and gene/ tolerance, and obesity [7]. protein expression [2]. Liraglutide previously has been Endocrine (2019) 64:349–366 351 shown to induce differentiation in the presence of differ- # I9278) were procured from Sigma-Aldrich Chemicals Co., entiation medium consisting of insulin (IN), dexamethasone USA. Mouse Adipokine antibody array kit was obtained (DEX), and 3-isobutyl-1-methylxanthine (IBMX) [19]. from R&D Systems, USA (Catalog # ARY013). Other However, whether liraglutide alone has any effect on the chemicals of analytical grade were purchased from Sigma- differentiation of the 3T3L1 pre-adipocytes has not been Aldrich Chemicals Co., USA. studied. Antibody, cata- Host Type Source Supplier Dilution Since 1935, Stein and Leventhal [27] had recognized log number species IB/IHC obesity as a common feature of the PCOS, one of the GLUT-4 (H- Rabbit Polyclonal Human Santa Cruz Biotechnol- 1:500 common metabolic disorders of females, characterized by 61):sc-7938 ogy Inc., CA, USA hyperandrogenism and chronic oligo-anovulation [28]. Adipo R1 (H- Rabbit Polyclonal
Load more

Recommended publications
  • Multifaceted Physiological Roles of Adiponectin in Inflammation And
    International Journal of Molecular Sciences Review Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases Hyung Muk Choi 1, Hari Madhuri Doss 1,2 and Kyoung Soo Kim 1,2,* 1 Department of Clinical Pharmacology and Therapeutics, Kyung Hee University School of Medicine, Seoul 02447, Korea; [email protected] (H.M.C.); [email protected] (H.M.D.) 2 East-West Bone & Joint Disease Research Institute, Kyung Hee University Hospital at Gangdong, Gandong-gu, Seoul 02447, Korea * Correspondence: [email protected]; Tel.: +82-2-961-9619 Received: 3 January 2020; Accepted: 10 February 2020; Published: 12 February 2020 Abstract: Adiponectin is the richest adipokine in human plasma, and it is mainly secreted from white adipose tissue. Adiponectin circulates in blood as high-molecular, middle-molecular, and low-molecular weight isoforms. Numerous studies have demonstrated its insulin-sensitizing, anti-atherogenic, and anti-inflammatory effects. Additionally, decreased serum levels of adiponectin is associated with chronic inflammation of metabolic disorders including Type 2 diabetes, obesity, and atherosclerosis. However, recent studies showed that adiponectin could have pro-inflammatory roles in patients with autoimmune diseases. In particular, its high serum level was positively associated with inflammation severity and pathological progression in rheumatoid arthritis, chronic kidney disease, and inflammatory bowel disease. Thus, adiponectin seems to have both pro-inflammatory and anti-inflammatory effects. This indirectly indicates that adiponectin has different physiological roles according to an isoform and effector tissue. Knowledge on the specific functions of isoforms would help develop potential anti-inflammatory therapeutics to target specific adiponectin isoforms against metabolic disorders and autoimmune diseases.
    [Show full text]
  • (Title of the Thesis)*
    THE PHYSIOLOGICAL ACTIONS OF ADIPONECTIN IN CENTRAL AUTONOMIC NUCLEI: IMPLICATIONS FOR THE INTEGRATIVE CONTROL OF ENERGY HOMEOSTASIS by Ted Donald Hoyda A thesis submitted to the Department of Physiology In conformity with the requirements for the degree of Doctor of Philosophy Queen‟s University Kingston, Ontario, Canada (September, 2009) Copyright © Ted Donald Hoyda, 2009 ABSTRACT Adiponectin regulates feeding behavior, energy expenditure and autonomic function through the activation of two receptors present in nuclei throughout the central nervous system, however much remains unknown about the mechanisms mediating these effects. Here I investigate the actions of adiponectin in autonomic centers of the hypothalamus (the paraventricular nucleus) and brainstem (the nucleus of the solitary tract) through examining molecular, electrical, hormonal and physiological consequences of peptidergic signalling. RT-PCR and in situ hybridization experiments demonstrate the presence of AdipoR1 and AdipoR2 mRNA in the paraventricular nucleus. Investigation of the electrical consequences following receptor activation in the paraventricular nucleus indicates that magnocellular-oxytocin cells are homogeneously inhibited while magnocellular-vasopressin neurons display mixed responses. Single cell RT-PCR analysis shows oxytocin neurons express both receptors while vasopressin neurons express either both receptors or one receptor. Co-expressing oxytocin and vasopressin neurons express neither receptor and are not affected by adiponectin. Median eminence projecting corticotropin releasing hormone neurons, brainstem projecting oxytocin neurons, and thyrotropin releasing hormone neurons are all depolarized by adiponectin. Plasma adrenocorticotropin hormone concentration is increased following intracerebroventricular injections of adiponectin. I demonstrate that the nucleus of the solitary tract, the primary cardiovascular regulation site of the medulla, expresses mRNA for AdipoR1 and AdipoR2 and mediates adiponectin induced hypotension.
    [Show full text]
  • Metabolic Syndrome: Is It Time to Add the Central Nervous System?
    nutrients Review Metabolic Syndrome: Is It Time to Add the Central Nervous System? Milagros Rojas 1, Mervin Chávez-Castillo 2, Daniela Pirela 1, Heliana Parra 1 , Manuel Nava 1, Maricarmen Chacín 3, Lissé Angarita 4 , Roberto Añez 5, Juan Salazar 1 , Rina Ortiz 6, Samuel Durán Agüero 7, Marbel Gravini-Donado 8, Valmore Bermúdez 9 and Edgar Díaz-Camargo 9,* 1 Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo 4004, Venezuela; migarocafi@gmail.com (M.R.); [email protected] (D.P.); [email protected] (H.P.); [email protected] (M.N.); [email protected] (J.S.) 2 Psychiatric Hospital of Maracaibo, Maracaibo 4004, Venezuela; [email protected] 3 Facultad de Ciencias de la Salud, Universidad Simón Bolívar, Barranquilla 08002, Colombia; [email protected] 4 Escuela de Nutrición y Dietética, Facultad de Medicina, Universidad Andrés Bello, Sede Concepción 4260000, Chile; [email protected] 5 Departamento de Endocrinología y Nutrición, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain; [email protected] 6 Posgrado, Carrera de Medicina, Universidad Católica de Cuenca, Cantón de Cuenca 010101, Ecuador; [email protected] 7 Facultad de Ciencias Para el Cuidado de la Salud, Universidad San Sebastián, Los Leones 8420524, Chile; [email protected] 8 Facultad de Ciencias Jurídicas y Sociales, Universidad Simón Bolívar, Barranquilla 080002, Colombia; [email protected] 9 Facultad de Ciencias Jurídicas y Sociales, Universidad Simón Bolívar, Cúcuta 540006, Colombia; [email protected] * Correspondence: [email protected] Citation: Rojas, M.; Chávez-Castillo, M.; Pirela, D.; Parra, H.; Nava, M.; Abstract: Metabolic syndrome (MS) is a set of cardio-metabolic risk factors that includes central Chacín, M.; Angarita, L.; Añez, R.; obesity, hyperglycemia, hypertension, and dyslipidemias.
    [Show full text]
  • ADIPOQ) and the Type 1 Receptor (ADIPOR1), Obesity and Prostate Cancer in African Americans
    Prostate Cancer and Prostatic Diseases (2010) 13, 362–368 & 2010 Macmillan Publishers Limited All rights reserved 1365-7852/10 www.nature.com/pcan ORIGINAL ARTICLE Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans JL Beebe-Dimmer1, KA Zuhlke2, AM Ray2, EM Lange3 and KA Cooney4 1Department of Population Studies and Prevention, Karmanos Cancer Institute, Department of Internal Medicine, Wayne State University, Detroit, MI, USA; 2Departments of Internal Medicine and Urology, University of Michigan Medical School, Ann Arbor, MI, USA; 3Departments of Genetics and Biostatistics, University of North Carolina, Chapel Hill, NC, USA and 4Departments of Internal Medicine and Urology, University of Michigan Medical School, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA Adiponectin is a protein derived from adipose tissue suspected to have an important role in prostate carcinogenesis. Variants in the adiponectin gene (ADIPOQ) and its type 1 receptor (ADIPOR1) have been recently linked to risk of both breast and colorectal cancer. Therefore, we set out to examine the relationship between polymorphisms in these genes, obesity and prostate cancer in study of African-American men. Ten single-nucleotide polymorphisms (SNPs) in ADIPOQ and ADIPOR1 were genotyped in DNA samples from 131 African-American prostate cancer cases and 344 controls participating in the Flint Men’s Health Study. Logistic regression was then used to estimate their association with prostate cancer and obesity. While no significant associations were detected between any of the tested SNPs and prostate cancer, the rs1501299 SNP in ADIPOQ was significantly associated with body mass (P ¼ 0.03).
    [Show full text]
  • Quantigene Flowrna Probe Sets Currently Available
    QuantiGene FlowRNA Probe Sets Currently Available Accession No. Species Symbol Gene Name Catalog No. NM_003452 Human ZNF189 zinc finger protein 189 VA1-10009 NM_000057 Human BLM Bloom syndrome VA1-10010 NM_005269 Human GLI glioma-associated oncogene homolog (zinc finger protein) VA1-10011 NM_002614 Human PDZK1 PDZ domain containing 1 VA1-10015 NM_003225 Human TFF1 Trefoil factor 1 (breast cancer, estrogen-inducible sequence expressed in) VA1-10016 NM_002276 Human KRT19 keratin 19 VA1-10022 NM_002659 Human PLAUR plasminogen activator, urokinase receptor VA1-10025 NM_017669 Human ERCC6L excision repair cross-complementing rodent repair deficiency, complementation group 6-like VA1-10029 NM_017699 Human SIDT1 SID1 transmembrane family, member 1 VA1-10032 NM_000077 Human CDKN2A cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) VA1-10040 NM_003150 Human STAT3 signal transducer and activator of transcripton 3 (acute-phase response factor) VA1-10046 NM_004707 Human ATG12 ATG12 autophagy related 12 homolog (S. cerevisiae) VA1-10047 NM_000737 Human CGB chorionic gonadotropin, beta polypeptide VA1-10048 NM_001017420 Human ESCO2 establishment of cohesion 1 homolog 2 (S. cerevisiae) VA1-10050 NM_197978 Human HEMGN hemogen VA1-10051 NM_001738 Human CA1 Carbonic anhydrase I VA1-10052 NM_000184 Human HBG2 Hemoglobin, gamma G VA1-10053 NM_005330 Human HBE1 Hemoglobin, epsilon 1 VA1-10054 NR_003367 Human PVT1 Pvt1 oncogene homolog (mouse) VA1-10061 NM_000454 Human SOD1 Superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))
    [Show full text]
  • Suppression of Adiponectin Receptor 1 Promotes Memory Dysfunction And
    www.nature.com/scientificreports OPEN Suppression of adiponectin receptor 1 promotes memory dysfunction and Alzheimer’s Received: 23 May 2017 Accepted: 8 September 2017 disease-like pathologies Published: xx xx xxxx Min Woo Kim, Noman bin Abid, Myeong Hoon Jo, Min Gi Jo, Gwang Ho Yoon & Myeong Ok Kim Recent studies on neurodegeneration have focused on dysfunction of CNS energy metabolism as well as proteinopathies. Adiponectin (ADPN), an adipocyte-derived hormone, plays a major role in the regulation of insulin sensitivity and glucose homeostasis in peripheral organs via adiponectin receptors. In spite of accumulating evidence that adiponectin has neuroprotective properties, the underlying role of adiponectin receptors has not been illuminated. Here, using gene therapy-mediated suppression with shRNA, we found that adiponectin receptor 1 (AdipoR1) suppression induces neurodegeneration as well as metabolic dysfunction. AdipoR1 knockdown mice exhibited increased body weight and abnormal plasma chemistry and also showed spatial learning and memory impairment in behavioural studies. Moreover, AdipoR1 suppression resulted in neurodegenerative phenotypes, diminished expression of the neuronal marker NeuN, and increased expression and activity of caspase 3. Furthermore, AD-like pathologies including insulin signalling dysfunction, abnormal protein aggregation and neuroinfammatory responses were highly exhibited in AdipoR1 knockdown groups, consistent with brain pathologies in ADPN knockout mice. Together, these results suggest that ADPN- AdipoR1 signalling has the potential to alleviate neurodegenerative diseases such as Alzheimer’s diseases. Neurodegeneration is a term describing a pathological phenotype observed in the central nervous system, espe- cially the brain1. Many etiological models of neurodegeneration, such as that in Alzheimer’s disease (AD) and Parkinson’s disease (PD), are based on abnormal protein aggregation and sequentially entail chronic infamma- tion, generation of reactive oxygen species (ROS) and apoptosis2–4.
    [Show full text]
  • Adiponectin Receptor As a Key Player in Healthy Longevity and Obesity-Related Diseases
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Cell Metabolism Review Adiponectin Receptor as a Key Player in Healthy Longevity and Obesity-Related Diseases Toshimasa Yamauchi1,* and Takashi Kadowaki1,* 1Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan *Correspondence: [email protected] (T.Y.), [email protected] (T.K.) http://dx.doi.org/10.1016/j.cmet.2013.01.001 Adiponectin is a fat-derived hormone whose reduction plays central roles in obesity-linked diseases including insulin resistance/type 2 diabetes and atherosclerosis. The cloning of Adiponectin receptors AdipoR1 and AdipoR2 has stimulated adiponectin research, revealing pivotal roles for AdipoRs in pleiotropic adiponectin actions, as well as some postreceptor signaling mechanisms. Adiponectin signaling has thus become one of the major research fields in metabolism and clinical medicine. Studies on AdipoRs will further our understanding of the role of adiponectin in obesity-linked diseases and shortened life span and may guide the design of antidiabetic and antiaging drugs with AdipoR as a target. Background et al., 1994; Lazar, 2006). Some of these adipokines have been Roles of Adipokines in Obesity-Related Diseases shown to directly or indirectly affect insulin sensitivity through The prevalence of obesity has increased dramatically in recent modulation of insulin signaling and the molecules involved in years (Friedman, 2000). It is commonly associated with type 2 glucose and lipid metabolism. Of these adipokines, adiponectin diabetes, dyslipidemia, and hypertension, and the coexistence has recently attracted much attention because of its antidiabetic of these diseases has been termed metabolic syndrome, which and antiatherogenic effects as well as its antiproliferative effects is related to atherosclerosis (Reaven, 1997; Matsuzawa, 1997).
    [Show full text]
  • Characterization of Feline Adiponectin and Its Association with Metabolic Indices in Lean and Obese Cats
    University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Doctoral Dissertations Graduate School 8-2009 Characterization of Feline Adiponectin and its Association with Metabolic Indices in Lean and Obese Cats Angela Lea Lusby University of Tennessee - Knoxville Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss Part of the Medicine and Health Sciences Commons Recommended Citation Lusby, Angela Lea, "Characterization of Feline Adiponectin and its Association with Metabolic Indices in Lean and Obese Cats. " PhD diss., University of Tennessee, 2009. https://trace.tennessee.edu/utk_graddiss/72 This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. To the Graduate Council: I am submitting herewith a dissertation written by Angela Lea Lusby entitled "Characterization of Feline Adiponectin and its Association with Metabolic Indices in Lean and Obese Cats." I have examined the final electronic copy of this dissertation for form and content and recommend that it be accepted in partial fulfillment of the equirr ements for the degree of Doctor of Philosophy, with a major in Comparative and Experimental Medicine. Claudia Kirk, Major Professor We have read this dissertation and recommend its acceptance: Joseph Bartges, Stephen
    [Show full text]
  • Adiponectin Receptors: a Review of Their Structure, Function and How They Work
    Best Practice & Research Clinical Endocrinology & Metabolism 28 (2014) 15–23 Contents lists available at ScienceDirect Best Practice & Research Clinical Endocrinology & Metabolism journal homepage: www.elsevier.com/locate/beem 2 Adiponectin receptors: A review of their structure, function and how they work Toshimasa Yamauchi*, Masato Iwabu, Miki Okada-Iwabu, Takashi Kadowaki* Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan The discovery of adiponectin and subsequently the receptors it Keywords: adipokine acts upon have lead to a great surge forward in the understanding adiponectin of the development of insulin resistance and obesity-linked dis- adiponectin receptors AdipoRs eases. Adiponectin is a hormone that is derived from adipose tis- insulin resistance sue and is reduced in obesity-linked diseases including insulin obesity resistance/type 2 diabetes and atherosclerosis. Adiponectin exerts type 2 diabetes its effects by binding to adiponectin receptors, two of which, atherosclerosis AdipoR1 and AdipoR2, have been cloned. This has enabled re- metabolic syndrome searchers to carry out detailed studies elucidating the role played AMPK PPAR by these receptors and the metabolic pathways that are involved ceramide following their activation. Such studies have clearly shown that the S1P stimulation of these receptors is associated with glucose homeo- mitochondria stasis and ongoing research into their role will clarify the under- exercise lying molecular mechanisms of adiponectin. Such knowledge can inflammasome then be used to provide therapeutic targets aimed at managing NF-kappaB obesity-linked diseases including type 2 diabetes and metabolic COX2 syndrome. food intake Ó 2013 Elsevier Ltd. All rights reserved.
    [Show full text]
  • RT² Profiler PCR Array (Rotor-Gene® Format) Mouse Obesity
    RT² Profiler PCR Array (Rotor-Gene® Format) Mouse Obesity Cat. no. 330231 PAMM-017ZR For pathway expression analysis Format For use with the following real-time cyclers RT² Profiler PCR Array, Rotor-Gene Q, other Rotor-Gene cyclers Format R Description The Mouse Obesity RT² Profiler PCR Array profiles the expression of 84 genes related to obesity. The control of a relative stable body weight depends on a complex interaction among the hormone axes in the peripheral nervous system and neurotransmitter signals in the central nervous system that play a crucial role in maintaining a balanced energy metabolism. This PCR Array includes obesity-related genes that are directly involved in the regulation of energy intake and expenditure. The genes encode for orexigenic peptides, hormones, and receptors; anorectic peptides, hormones, receptors; and central and peripheral signaling molecules involved in energy expenditure. Using real-time PCR, you can easily and reliably analyze expression of a focused panel of genes related to Obesity with this array. For further details, consult the RT² Profiler PCR Array Handbook. Shipping and storage RT² Profiler PCR Arrays in the Rotor-Gene format are shipped at ambient temperature, on dry ice, or blue ice packs depending on destination and accompanying products. For long term storage, keep plates at –20°C. Note: Ensure that you have the correct RT² Profiler PCR Array format for your real-time cycler (see table above). Note: Open the package and store the products appropriately immediately on receipt. Sample & Assay Technologies Array layout The 96 real-time assays in the Rotor-Gene format are located in wells 1–96 of the Rotor-Disc™ (plate A1–A12=Rotor-Disc 1–12, plate B1–B12=Rotor-Disc 13–24, etc.).
    [Show full text]
  • Adiponectin Receptors Are Expressed in Hypothalamus and Colocalized with Proopiomelanocortin and Neuropeptide Y in Rodent Arcuate Neurons
    93 Adiponectin receptors are expressed in hypothalamus and colocalized with proopiomelanocortin and neuropeptide Y in rodent arcuate neurons E Guillod-Maximin*, A F Roy*, C M Vacher, A Aubourg, V Bailleux, A Lorsignol1,LPe´nicaud1, M Parquet and M Taouis UMR 1197, Universite´ Paris-Sud 11/INRA, NMPA, Bat 447, 91405 Orsay Cedex, France 1UMR 5241 CNRS-UPS, BP 84225, 31432 Toulouse Cedex 4, France (Correspondence should be addressed to M Parquet; Email: [email protected]) *(E Guillod-Maximin and A F Roy equally contribute to this work) Abstract Adiponectin is involved in the control of energy homeostasis in showed that Adipor1 and Adipor2 were present in pro– peripheral tissues through Adipor1 and Adipor2 receptors. An opiomelanocortin (POMC) and neuropeptide Y (NPY) neurons increasing amount of evidence suggests that this adipocyte- in the arcuate nucleus. Finally, adiponectin treatment by secreted hormone may also act at the hypothalamic level to intracerebroventricular injection induced AMP-activated control energy homeostasis. In the present study, we observed protein kinase (AMPK) phosphorylation in the rat hypothalamus. the gene and protein expressions of Adipor1 and Adipor2 in rat This was confirmed by in vitro studies using hypothalamic hypothalamus using different approaches. By immunohisto- membrane fractions. In conclusion, Adipor1 and Adipor2 are chemistry, Adipor1 expression was ubiquitous in the rat brain. both expressed by neurons (including POMC and NPY neurons) By contrast, Adipor2 expression was more limited to specific and astrocytes in the rat hypothalamic nuclei. Adiponectin is able brain areas such as hypothalamus, cortex, and hippocampus. In to increase AMPK phosphorylation in the rat hypothalamus.
    [Show full text]
  • Overexpression of Adiponectin Receptor 1 Inhibits Brown and Beige Adipose Tissue Activity in Mice
    International Journal of Molecular Sciences Article Overexpression of Adiponectin Receptor 1 Inhibits Brown and Beige Adipose Tissue Activity in Mice Yu-Jen Chen 1,2,*, Chiao-Wei Lin 1,2, Yu-Ju Peng 2, Chao-Wei Huang 2 , Yi-Shan Chien 2, Tzu-Hsuan Huang 2, Pei-Xin Liao 2, Wen-Yuan Yang 2, Mei-Hui Wang 3, Harry J. Mersmann 2, Shinn-Chih Wu 1,2, Tai-Yuan Chuang 4, Yuan-Yu Lin 2,* , Wen-Hung Kuo 5,* and Shih-Torng Ding 1,2,* 1 Institute of Biotechnology, National Taiwan University, Taipei 10617, Taiwan; [email protected] (C.-W.L.); [email protected] (S.-C.W.) 2 Department of Animal Science and Technology, National Taiwan University, Taipei 10617, Taiwan; [email protected] (Y.-J.P.); [email protected] (C.-W.H.); [email protected] (Y.-S.C.); [email protected] (T.-H.H.); [email protected] (P.-X.L.); [email protected] (W.-Y.Y.); [email protected] (H.J.M.) 3 Institute of Nuclear Energy Research, Taoyuan 325, Taiwan; [email protected] 4 Department of Athletics, National Taiwan University, Taipei 10617, Taiwan; [email protected] 5 Department of Surgery, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei 10617, Taiwan * Correspondence: [email protected] (Y.-J.C.); [email protected] (Y.-Y.L.); [email protected] (W.-H.K.); [email protected] (S.-T.D.); Tel.: +886-2-3366-4175 (S.-T.D.) Abstract: Adult humans and mice possess significant classical brown adipose tissues (BAT) and, upon cold-induction, acquire brown-like adipocytes in certain depots of white adipose tissues (WAT), known as beige adipose tissues or WAT browning/beiging.
    [Show full text]